Other names: Ongentys®
Categories: Prescription Medication
Description:
Opicapone (Ongentys®) is a COMT inhibitor used with levodopa/carbidopa to help manage motor fluctuations in Parkinson’s disease. By blocking the breakdown of levodopa, it allows more drug to reach the brain and helps extend “on” time. Unlike entacapone, it is taken just once daily, making it more convenient for patients. Common side effects include dyskinesia, constipation, low blood pressure, and insomnia, though most people tolerate it well. Opicapone is especially useful for patients with advanced disease who need better control of “wearing-off” symptoms.
Treatment For:
AI generated Summary: Based on the provided information, there are no user reviews available for the treatment 'Opicapone' against 'Parkinson's Disease'. The author has not provided a review or rating for this treatment, making it difficult to determine its effectiveness without further data or clinical studies.
The information, including but not limited to, text, graphics, images and other material contained on this website/app are for informational purposes only. No material on this site/app is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website/app.
Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.
